Medication‐related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients

Abstract

Endodontic treatment failure should be considered a local risk factor for MRONJ development in oncologic patients. For such reason, it is mandatory to carefully evaluate them prior than the beginning of antiresorptive and antiangiogenic drugs administration.